Related Experiment Video
Updated: Sep 23, 2025

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
DIAPH3 is a prognostic biomarker and inhibit colorectal cancer progression through maintaining EGFR degradation
Renli Huang1, Cheng Wu2, Jialing Wen3
1Department of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Background:
Actin cytoskeleton is connected with the processes of cell proliferation and migration in colorectal cancer (CRC). However, it is unknown how to accomplish these adjustments in CRC by actin cytoskeleton genes (ACGs) and here we investigated the role of hub prognosis-related ACGs-Diaphanous-related formin 3 (DIAPH3) in CRC, as a potential, novel target.
Methods:
The ACGs gene set from the Kyoto Encyclopedia of Genes and Genomes (KEGG) was used to group CRC patients and select prognosis-related ACGs by univariate and multivariate Cox regression for constructing prognostic model. Next, we tested hub prognosis-related ACGs- DIAPH3 expression in CRC and clarified the role of DIAPH3 by shRNA constructs in KM12 and SW480. Activation of EGFR was analyzed by western blot and immunofluorescence.
Results:
The results showed that actin cytoskeleton function is a significant prognostic factor for CRC patients and related to clinicopathological characteristics such as T stage and lymph node metastasis. A prognostic model constructed by four prognosis-related ACGs has a moderate intensity to 1-year Survival (AUC = 0.71). And hub prognosis-related ACGs DIAPH3 is downregulated in CRC. Knockdown of DIAPH3 could promote the proliferation and migration capacity of CRC. In addition, DIAPH3-silenced cells increase EGFR phosphorylation by inhibiting EGFR transportation to lysosome.
Conclusions:
ACGs play a significant role in tumor invasion and have the potential to predict the prognosis of CRC. Prognosis-related ACGs DIAPH3 might be a new prognostic biomarker and DIAPH3 could inhibit CRC progression through maintaining EGFR degradation.
Insights
Actin cytoskeleton genes impact colorectal cancer (CRC) progression. Diaphanous-related formin 3 (DIAPH3) is downregulated in CRC, and its knockdown promotes cancer cell proliferation and migration by affecting EGFR signaling.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Actin cytoskeleton dynamics are crucial for colorectal cancer (CRC) cell proliferation and migration.
- The specific roles of actin cytoskeleton genes (ACGs) in CRC progression and their potential as therapeutic targets remain largely unexplored.
Purpose of the Study:
- To investigate the role of hub prognosis-related ACGs, specifically Diaphanous-related formin 3 (DIAPH3), in colorectal cancer (CRC).
- To evaluate DIAPH3 as a potential novel therapeutic target and prognostic biomarker in CRC.
Main Methods:
- Utilized the Kyoto Encyclopedia of Genes and Genomes (KEGG) ACGs gene set for patient grouping and Cox regression analysis to identify prognostic ACGs.
- Assessed DIAPH3 expression in CRC and its functional role using shRNA in CRC cell lines (KM12, SW480).
- Analyzed epidermal growth factor receptor (EGFR) activation via western blot and immunofluorescence.
Main Results:
- Actin cytoskeleton function is a significant prognostic factor in CRC, correlating with T stage and lymph node metastasis.
- A prognostic model based on four ACGs demonstrated moderate 1-year survival prediction (AUC = 0.71).
- DIAPH3 was found to be downregulated in CRC; its knockdown enhanced CRC cell proliferation and migration, and increased EGFR phosphorylation by inhibiting lysosomal transport.
Conclusions:
- ACGs are significant in CRC invasion and prognosis prediction.
- DIAPH3 shows potential as a novel prognostic biomarker for CRC.
- DIAPH3 may inhibit CRC progression by regulating EGFR degradation.
Related Concept Videos
Mitogens and the Cell Cycle
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

